The purpose of this paper was to compare cell-free DNA (cfDNA) and cell-free RNA (cfRNA) yields obtained from citrate and EDTA plasma of healthy volunteers using six different co-isolation methods. The effects of plasma volume on cfDNA and cfRNA yield and eluate volume on digital PCR amplification were also investigated.
Digital PCR-based evaluation of nucleic acid extraction kit performance for the co-purification of cell-free DNA and RNA.
Deleu J, Schoofs K, Decock A, Verniers K, Roelandt S, Denolf A, Verreth J, De Wilde B, Van Maerken T, De Preter K, Vandesompele J
Purpose
Conclusion
cfDNA and cfRNA yields increased with as plasma input volume increased (0.06-4 mL), regardless of extraction method, but there was little variation between EDTA and citrate plasma and among donors. The highest cfRNA and cfDBA concentrations were obtained using the iCatcher Circulating cfDNA/cfRNA 4000 Kit followed by the QIAamp ccfDNA/RNA Kit; however, the eluate volume from the iCatcher Circulating cfDNA/cfRNA 4000 Kit was highly variable. When the volume of eluate that was used as input for real-time PCR amplification was increased (from 10% to 40% of the reaction volume), amplification increased accordingly indicating the absence of PCR inhibitors. Importantly, the ability to increase input volume without introducing PCR inhibition permitted an increase in sensitivity. Intriguingly, when cfDNA and cfRNA were co-purified from the plasma of three healthy volunteers using the miRNeasy Serum/Plasma Advanced Kit, the sum of the separately measured cfDNA and cfRNA concentrations was lower than the jointly measured concentration.
Studies (1)
Purpose
The purpose of this study was to compare cfDNA and cfRNA yields obtained from citrate and EDTA plasma of healthy volunteers using six different co-isolation methods. The effects of plasma volume on cfDNA and cfRNA yield and eluate volume on digital PCR amplification were also investigated. Blood was collected from three healthy volunteers into EDTA and citrate tubes. Plasma was isolated by centrifugation (twice at 2500 x g for 15 min) and then stored at -80°C. cfDNA and cfRNA were coextracted from 0.06-4 mL of plasma using the miRNeasy Serum/Plasma Advanced Kit, QIAamp ccfDNA/RNA Kit, iCatcher Circulating cfDNA/cfRNA 4000 kit, MagNA Pure 24 Total NA Isolation Kit, Maxwell ccfDNALV Plasma Kit, and the miRNeasy Serum/Plasma Kit. Isolated cfDNA and cfRNA were stored at -80°C. DNA was removed from cfRNA by DNase treatment and reverse transcribed using the iScript Advanced cDNA Synthesis Kit. cfDNA and cfRNA were quantified by the same duplex digital PCR assays amplifying CAVIN2/NRGN and AIF1/B2M. Total cfDNA and cfRNA were quantified together using the same digital PCR assays to amplify cDNA from cfRNA that was not DNase-treated and thus still contained cfDNA. cfDNA fragment size was analyzed using a TapeStation instrument.
Summary of Findings
cfDNA and cfRNA yields increased as plasma input volume increased (0.06-4 mL), regardless of extraction method, and there was little variation between EDTA and citrate plasma and among donors. The eluate volume from the iCatcher Circulating cfDNA/cfRNA 4000 Kit was highly variable (18-27 µL), but the eluate volume with the other kits was reproducible. Nevertheless, the highest cfRNA concentrations were obtained using the iCatcher Circulating cfDNA/cfRNA 4000 Kit followed by the QIAamp ccfDNA/RNA Kit. Similarly, the highest cfDNA concentrations were obtained using the iCatcher Circulating cfDNA/cfRNA 4000 Kit followed by the QIAamp ccfDNA/RNA Kit and the single strand protocol of the MagNA Pure 24 Total NA Isolation Kit. Overall, the percentage of isolated DNA that was ~170 bp ranged from 64-94%, indicating that all kits successfully isolated cfDNA. When the volume of eluate that was used as input for real-time PCR amplification was increased (from 10% to 40% of the reaction volume),, amplification increased accordingly indicating the absence of PCR inhibitors. Importantly, the ability to increase input volume without PCR inhibition permitted an increase in sensitivity. Intriguingly, when cfDNA and cfRNA were co-purified from the plasma of three healthy volunteers using the miRNeasy Serum/Plasma Advanced Kit, the sum of the separately measured cfDNA and cfRNA concentrations was lower than the jointly measured concentration. The authors state this may be attributable a negative effect of the DNAse treatment step on cfRNA concentration or that cDNA synthesis increases cfDNA quantification.
Biospecimens
FluidBloodFluidPlasmaPreservation Types
FrozenDiagnoses
NormalPlatforms
DNAAutomated electrophoresis/BioanalyzerDNADigital PCRRNADigital PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant CitrateEDTABiospecimen Aliquots and Components Aliquot size/volume 0.06 mL plasma0.2 mL plasma0.6 mL plasma1.0 mL plasma2.0 mL plasma4.0 mL plasmaAnalyte Extraction and Purification Analyte isolation method MagNA Pure 24 Total NA Isolation KitMaxwell ccfDNALV Plasma KitQIAamp ccfDNA/RNA KitiCatcher Circulating cfDNA/cfRNA 4000 kitmiRNeasy Serum/Plasma Advanced KitmiRNeasy Serum/Plasma KitDigital PCR Specific Targeted nucleic acid AIF1/B2MCAVIN2/NRGNDigital PCR Specific Template/input amount 10% of reaction volume20% of reaction volume30% of reaction volume40% of reaction volume